Connection

Ashish Deshmukh to Receptor, ErbB-2

Back to Details
This is a "connection" page, showing publications Ashish Deshmukh has written about Receptor, ErbB-2.
Ashish Deshmukh
Connection Strength
0.048
Receptor, ErbB-2
  1. Cost Effectiveness of CDK4/6 Inhibitors in the First-Line Treatment of HR+/HER2- Metastatic Breast Cancer in Postmenopausal Women in the USA. Pharmacoeconomics. 2023 Jun; 41(6):709-718.
    View in: PubMed
    Score: 0.048
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.